Arsenicum album â?? 30 as prophylactic for Covid-19
Phase 2
- Registration Number
- CTRI/2020/05/025205
- Lead Sponsor
- Central Council for Research in Homoeopathy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
•High risk contacts of Covid 19 infection who are asymptomatic and residing in hotspots.
•Age 1 year & above
•Both gender
•Willing to give verbal informed consent or written informed consent as the situation may be (keeping in view contagious nature of disease)
Exclusion Criteria
•Pregnant women or lactating mothers
•Immunocompromised individuals on basis of medical history.
•Symptomatic (similar to COVID-19) cases at quarantine zone.
•Not willing to give informed consent/verbal consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Confirmation of diagnosis for COVID-19 infection based on RT-PCR / end of quarantine period as per standard protocol.Timepoint: Every third day till 21st day.
- Secondary Outcome Measures
Name Time Method 1. To compare the asymptomatic/symptomatic Covid-19 positive cases between the groups. <br/ ><br>2. To compare time to appearance of clinical symptoms of COVID-19 infections. <br/ ><br>3. To compare time to confirmation of diagnosis for COVID-19 (Laboratory findings) <br/ ><br>Timepoint: Every third day till 21st day.